Genomize is a bioinformatics company that aims to support medical genetic physicians and researchers in the rapid and reliable detection and analysis of genetic variants through our software, SEQ Platform. Our expertise focuses solely on the secondary and tertiary analysis of data obtained from Next Generation Sequencing (NGS). SEQ Platform is a cloud-based, CE-IVD certified, KVKK compliant variant detection, visualization, and analysis tool designed to provide rapid and reliable diagnoses from NGS data. With its artificial intelligence-powered variant prioritization feature and easy-to-use interface, SEQ Platform allows users to perform long-read, whole-genome, and whole-exome sequencing analyses starting from FASTQ, VCF, or gVCF formats. SEQ Platform has been implemented in over 400 hospitals and laboratories in more than 25 countries to date and has contributed to the analysis of data from over 275,000 individuals. You can review our technical articles on our website to learn more about the features we offer.
Other R&D Companies
Explore other companies under Bogazici Technopark.
